Purpose. Pili contribute significantly to the pathogenesis of infection of group B Streptococcus (GBS) by facilitating adhesion and invasion of host cells. GBS pilin subunits (the backbone pilin protein, BP, and the ancillary pilin proteins, AP) as well as the specific enzymes required for pilus assembly are encoded by genes located in two separate genomic regions, known as pilus island 1 (PI-1) and PI-2. Our aim was to characterize the pilus profile of a collection of GBS isolates from metropolitan Toronto, Canada.
INTRODUCTION
Group B Streptococcus (GBS), also known as Streptococcus agalactiae, is a leading cause of neonatal bacterial sepsis and meningitis, as well as an emerging cause of opportunistic invasive disease in adults [1] . Ten GBS serotypes (Ia, Ib and II to IX) are defined based on a serological reaction directed against the capsular polysaccharide (CPS), a surface structure expressed by GBS strains which endows the bacteria with resistance against phagocytosis [2] [3] [4] . Many other virulence factors also contribute to the GBS pathogenesis of infection [2] . For example, GBS strains commonly express pili, which can facilitate invasion and translocation of epithelial barriers [5] and reduce internalization and intracellular killing of GBS by human monocyte-derived macrophages [6] . GBS pili are encoded by genes which cluster at two distinct genomic regions known as pilus islands (PI) 1 and 2. Present in each of the PI are genes encoding LPXTG-motifcontaining pilin proteins, of which one is the pilus backbone protein (BP), and the others are the two ancillary pilus proteins (AP) [7] . Both PI also contain genes encoding specific class C sortase enzymes which catalyze pilus polymerization [8, 9] . The pilus profile of GBS isolates can be determined using a multiplex PCR scheme [10] . Data from epidemiological studies have shown that the genomes of GBS strains always contain one of two distinct variants of PI-2 (PI-2a or PI-2b) [8, 11] . Interestingly, PI-2a and PI-2b pilin proteins have been shown to share limited sequence similarity overall [7] . On the other hand, there is only one PI-1 variant, which may be present in, or absent from, the genome of GBS strains, in the latter case sometimes due to replacement of the entire PI-1 region by mobile genetic elements (MGEs) [12] [13] [14] . The PI-1 main pilin subunit BP-1 is highly conserved among different GBS serotypes and genetic backgrounds, and PI-1 APs have a relatively high degree of conservation in comparison to PI-2 AP subunits. Vaccination using different combinations of GBS pilin subunits is an interesting strategy to provide protection against the different GBS serotypes, and studies have shown that this strategy offers protection against homologous and heterologous challenges in murine experimental assays [15, 16] .
While determining the pilus profile of a collection of 1332 GBS isolates from Toronto, Canada, we discovered that 3.8 % of the isolates possessed a novel BP-1 variant (named BP-1b), which is not detectable by a commonly used multiplex PCR assay [10] . Here, we present a new primer pair that can be incorporated into the multiplex PCR assay to detect this variant. We also characterize at the genetic level both BP-1b and the PI-1 of these isolates. We also briefly discuss the implications of BP-1b for pilin-based GBS vaccine formulations.
METHODS
Bacterial strains GBS isolates were recovered between January 1, 2009-June 30, 2015 by the Toronto Invasive Bacterial Diseases Network, a population-based surveillance system for invasive bacterial diseases in Metropolitan Toronto and Peel region, Ontario, Canada. A total of 1332 isolates were collected, including carriage isolates from pregnant women (n=102) and invasive isolates (n=1230, patient age 0 days-98 years old). All hemolytic and non-hemolytic GBS isolates were identified using standard methods and were positive for presence of GBS antigen or positively identified as GBS by the use of matrix-assisted laser desorption ionization timeof-flight mass spectrometry. Bacteria used in this study were grown at 37 C with 5 % CO 2 on Columbia agar plates with 5 % sheep blood.
DNA preparations
Template DNA for PCR amplifications was prepared by boiling the strains for 5 min in a 0.2 N NaOH solution followed by centrifugation, after which the supernatants were stored at À20 C until use. Purified DNA for whole genome sequencing (WGS) library preparations was extracted from bacteria harvested from overnight cultures grown at 37 C in Todd-Hewitt broth supplemented with 0.2 % yeast extract using the QIAamp DNA minikit (Qiagen), following the manufacturer's protocol for Gram-positive organisms.
Molecular typing
PCR amplification of a region of the gene dltR was used to confirm species identification [17, 18] . All isolates were next typed by PCR for pilus island profile using oligonucleotide primers targeting genes of the PI-1 and PI-2 loci as previously described [10] , as well as using the primers described here (Table 1) . We performed two multiplex PCR reactions for each bacterial isolate; the first containing primers PI1-UP, PI1-DN, PI1_all-UP, PI1_all-DN, and PI1b-UP and PI1b-DN. Briefly, 2 µl of DNA template lysate (prepared as described above) was added to the PCR mixture containing 10 µl KOD Master Mix (Toyobo) and 0.5 µM of each primer (Life Technologies), in a final volume of 20 µl. PCR conditions for amplification were: initial denaturation at 95 C for 2 min followed by 35 cycles of 95 C for 30 s, 50 C for 30 s, and 72 C for 45 s, with final extension at 72 C for 5 min. The second multiplex reaction contained primers PI2a-UP, PI2a-DN, PI2b-UP, and PI2b-DN, and conditions were the same except that an annealing temperature of 45 C was used. The PCR products were electrophoresed in 1 % (w/v) agarose gels, followed by SYBR Safe (ThermoFisher Scientific) staining and visualization using a standard 300 nm UV transilluminator. GBS capsular types were determined by multiplex PCR amplification of CPS type-specific regions of the cps locus as described previously [19] . All PCR reactions were carried out in Bio-Rad C1000 or S1000 instruments.
Whole genome sequencing and bioinformatics analysis Genomic libraries were prepared using Nextera XT kits (Illumina) and sequenced as paired-end reads in Illumina NextSeq or MiSeq instruments. Parsing of the multiplexed sequencing reads, and removal of barcode information was carried out using onboard software. The A5 pipeline [20] , run with default parameters, was used for de novo assembly of newly sequenced GBS genomes. Genome comparisons were carried out with Mauve [21] . Sequences were aligned using CLUSTALW [22] and amino acid sequence coloring was done with BOXSHADE (www.ch.embnet.org/software/BOX_ form.html).
RESULTS AND DISCUSSION
Characterization of the PI profile of 1332 GBS isolates A previously described multiplex PCR assay [10] was used to determine the pilus profile of 1332 GBS organisms collected in metropolitan Toronto between 2009 and 2015. The presence of PI-1 was revealed by the amplification of an 881 bp fragment of the PI-1 BP-encoding gene (gbs80, or SAG0645, in strain 2603 V/R; GenBank Accession number NC_004116.1:631950-633614) using primer pair PI1-UP/ PI1-DN. A second primer pair (PI1_all-UP/PI1_all-DN) permitted the amplification of a 684 bp amplicon corresponding to portions of two conserved genes that are contiguous when PI-1 is absent from the genome of the GBS strain, but that are separated by approximately 16 kbp when PI-1 or other genetic material (notably MGEs) is present. To differentiate between PI-2a and PI-2b, the multiplex assay includes two additional primer pairs targeting genes encoding APs found in the two divergent PI-2 islands, namely the genes encoding AP1-2a (amplicon of 575 bp) and AP1-2b (amplicon of 721 bp). Using this multiplex PCR assay, we determined that the majority of strains in our collection (1046/1332, 78.5 %) possessed PI-2a, while 286 strains (21.5 %) possessed PI-2b (Table 2) . Two strains were positive for PI-2a, but the obtained amplicon was larger in size ( Fig. S1 , available in the online Supplementary Material). Primer walking and Sanger sequencing data indicated that the increased size of the amplicon was due to the insertion of an 861 bp transposon into the gene encoding AP1-2a in these two strains (data not shown).
We determined by amplification of BP-1 that 894 strains (67.1 %) were positive for PI-1. A further 354 strains (26.6 %) were PCR positive for amplification of a fragment of DNA with primers PI1-all, i.e. according to this scheme, they possessed an 'empty' PI-1 locus. However, 84 strains (6.3 %) were negative for both PCR reactions (Table 2) . Recently, different publications have described that the PI-1 locus is a hotspot for MGE integration, which is often concurrent with loss of PI-1 [12, 23] . Therefore, we used whole genome sequencing (WGS) to test the hypothesis that in these 84 strains, PI-1 had been replaced by one or more MGEs. Consistent with the hypothesis, when we performed de novo assemblies of the WGS data from these 84 strains, we found in 33 strains that MGEs were indeed inserted at the PI-1 locus. There was a relatively high diversity of MGEs, with a total of 8 different elements (arbitrarily labeled A-H, Table S1 ), which ranged in size from 5.5 to 104.4 kbp and which, in some cases, contained antimicrobial resistance determinants (Fig. S2) .
In silico characterization of a novel GBS PI-1 BP variant Inspection of the de novo assembled genome sequences of the remaining 51 strains that were PCR negative with primer pairs PI-1 and PI-1_all failed to reveal MGE content integrated at the PI-1 locus. Instead, manual genome inspection of the de novo assembled sequences of these strains revealed a cluster of genes, organized as a legitimate PI-1 locus, and encoding one transcriptional regulator, one BP and two AP pilin subunits, and two class C sortases (Fig. 1a) . Comparisons using BLAST between the 51 strains and GBS strain 2603 V/R (GenBank Acccession Number NC_004116, the archetypical GBS reference genome used for GBS pili characterizations), showed that the nucleotide sequences of all genes in PI-1 with the exception of the one encoding the BP pilin subunit (i.e. those encoding the transcriptional regulator, the two AP subunits and the three sortases), as well as the amino acid sequences of each of their predicted translated gene products were highly homologous (98 % or more at the nucleotide level; 97 % or more at the amino acid level). On the other hand, BP-encoding genes differed, and the predicted translated sequence of the BP of these 51 strains and the BP-1 of strain 2603 V/R had only 63 % homology at the amino acid level (Fig. 1a) . We have named this novel BP-1 variant as BP-1b. The differences between the sequences of the BP-1 variants were limited to internal regions of the genes (Fig. 1b) and predicted translated protein sequences (Fig. 1c) . The three characteristic pilin motifs of BP proteins [24] were present in BP-1b. The failure to detect PI-1 in these 51 strains using the multiplex PCR assay [10] is thus explained by the fact that one of the previously described primers anneals to unique sequences of BP-1 which are absent in BP-1b (Fig. 1b) .
Primers for multiplex detection of the novel BP-1b gene variant We next sought to complement the multiplex PCR assay previously described by Martins et al. [10] by designing a new specific primer pair permitting the detection of novel BP-1b. The new primer pair (Table 1) can be easily incorporated into the current multiplex scheme. We obtained a positive result (i.e. an amplicon of 429 bp) in all 51 GBS strains possessing novel BP-1b using this extra primer pair, and the previously described multiplex PCR conditions (data not shown). Previous studies have used primers that anneal to sequences upstream and downstream of the gene encoding PI-1 BP [16] . Use of these 'external' primers would have permitted the amplification of the gene encoding novel BP1b. However, use of 'external' primers would have required a separate PCR reaction, and it would not have permitted to differentiate between BP-1 and BP-1b without additional Sanger sequencing of the generated PCR amplicons.
Novel BP-1b-encoding gene variant may have been acquired by recombination from a putative Streptococcus dysgalactiae donor When we performed a BLAST search of the National Center for Biotechnology Information (NCBI) non-redundant database using the full sequence of the gene encoding the novel BP-1b variant, we identified it in a fully closed genome of a GBS strain (strain GBS-M002, isolated in Taiwan in 2014, GenBank Accession Number CP013908.1) [25] . However, to the best of our knowledge, the existence of BP-1b has remained undescribed until now. In our collection, the occurrence of a PI-1 with the novel PI-1 BP variant was not restricted to a single serotype or sequence type (Table 3) , nor was it associated exclusively with either PI-2a or PI-2b (Table 3 ). The majority of BP-1b-containing isolates from our collection were serotype Ib, VI, and Ia, but we also identified BP-1b in strains of serotypes II, III, IV and VIII (Table 3 ). There was no obvious epidemiological clustering of these isolates. Although as a percentage of the total collection, BP-1b-containing strains were a minority (Table 3) , data from our study and those available at NCBI suggest that the BP-1b pilin subunit occurs relatively frequently among GBS isolates. Interestingly, when we performed a BLAST search with the sequence of the non-conserved portion of the BP-1b gene (Fig. 1a) , we found that it was 94 % identical to that of a putative BP subunit of Streptococcus dysgalactiae subsp. equisimilis strain UT-SS957 (GenBank Accession Number NZ_LAKT01000008.1). The homology between the novel GBS BP-1b amino acid sequence and the BP of S. dysgalactiae was also high (91 %) (Fig. 1c) . However, the similarities between the rest of the genes in the PI-1 of the 51 GBS strains with novel BP-1b and their homologues in S. dysgalactiae UT-SS957 were lower than those between our 51 strains and GBS strain 2603 V/R (Fig. 1a) . Based on these data, we speculate that the novel GBS BP-1b found in 51 of our strains has arisen due to homologous recombination of a short stretch of DNA acquired from a putative S. dysgalactiae subsp. equisimilis donor. This latter species is a commensal of the alimentary and genital tracts of humans, a niche which overlaps with that of GBS organisms colonizing healthy adults [26] [27] [28] [29] . Horizontal DNA acquisition appears to be facilitated during long periods of persistent GBS colonization [30] .
Implications for vaccination
Vaccination of pregnant women using CPS conjugate formulations has been proposed as a strategy for GBS prevention [28, 31, 32] . Maternal opsonizing antibodies can cross the placenta, and concentrations of anti-CPS IgG are inversely correlated with the risk of developing neonatal GBS disease [33, 34] . An interesting alternative, given the relatively large number of GBS serotypes and the geographical variability of GBS serotype prevalence [35, 36] , is the use of subunit vaccines [28] . Vaccine formulations using pilin subunits have been shown to be highly immunogenic and were able to elicit opsonophagocytic antibodies that conferred protection to mice [16] . A previous investigation has shown that the sequences of the different GBS pilin subunits were well conserved with the notable exception of the BP of PI-2a (BP-2a), of which at least 7 variants exist, with homology values ranging from 48 to 98 % [16] . These sequence differences were linked to the inability of BP-2a to provide cross-protection in animals immunized with the protein of a specific allele and challenged with strains carrying a different BP-2a allele [16] . Although experimental data will be needed to support this claim, it can be speculated that the relatively low level of homology between PI-1 variants BP-1 and BP-1b (63 %) may also lead to absence of cross protection if a vaccine formulation included solely one of these pilin subunits as immunogens. However, pilin based vaccine of the PI-1 locus in the archetypical GBS strain 2603 V/R (GenBank Accession number NC_004116.1). Third row: Genetic organization of the PI-1 locus in the 51 GBS strains that contain BP-1b, and BLAST identity of nucleotide sequences of each gene (percentage shown in black), and of the predicted translated amino acid sequences of each protein (in red) with the same genes and genes products of strain 2603 V/R. In all but one of the 51 strains, MGEs were detected between the conserved 5¢ gene (an RNA methyltransferase) and PI-1. Fourth row: Genetic organization of a putative pilus island in Streptococcus dysgalactiae subsp. equisimilis strain UT-SS957 (GenBank Accession Number NZ_LAKT01000008.1), and BLAST comparison of nucleotide sequences of each gene (in black), and of the predicted translated amino acid sequences of each protein (in red) to genes and gene products of the 51 strains with BP-1b. Note that in strain UT-SS957 the putative transcriptional regulator is annotated as a pseudogene; thus the amino acid homology reported here as 0% is due to the fact that strain UT-SS957 is not predicted to express this regulator. Genes are colored as per the legend. (b) Representation of the nucleotide sequences of BP-1 (top) and BP-1b (bottom) genes. Grey areas indicate conserved nucleotide sequence between the two variants, whereas areas in red and blue represent regions of difference. Annealing position of primers detecting PI-1 [10] and primers designed in this work to detect BP-1b are indicated by arrows above and below, respectively. (c) Amino acid alignment of the predicted translated sequence of BP-1 of strain 2603 V/R, predicted translated sequence of BP-1b of strain NGBS1454, and predicted translated sequence of the BP found in a putative pilus island of Streptococcus dysgalactiae subsp. equisimilis strain UT-SS957 (BP S. dysgalactiae). Identical amino acids are marked in dark grey, similar amino acids are coloured in light grey, and different amino acids are coloured white. Gaps in alignment are marked by dashes. Three motif sequences are marked by red horizontal lines; the Pilin motif (YPKN), the E box (LKET), and the LPXTG motif (IPNTG).
formulations include subunits from PI-2, and it has been shown that PI-1 AP alleles, of which we did not identify additional diversity among our collection of strains with BP-1b, offer cross protection against the heterologous challenge [15, 16] . Thus, we do not expect that the fact that some GBS strains may express BP-1b will jeopardize a pilinsubunit-based GBS vaccination strategy.
Concluding remarks
Our data show that the novel BP-1b variant occurs in a relatively important proportion of GBS isolates of various serotypes and genomic backgrounds. Expression studies are needed to determine what proportion of isolates that possess this gene variant actually express a PI-1 pilus. However, no molecular reasons preventing BP-1b expression and pilus formation were identified in our in silico analysis. In light of the inability of the widely used [13, [37] [38] [39] multiplex PCR scheme to detect BP-1b, and the potential for mistyping, it may be of interest to re-examine historic collections of GBS isolates using the primers described here to determine its true global prevalence. Further work will also be needed to understand the role of this pilus variant in the virulence of strains and the pathogenesis of GBS infection.
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